Mossman Associates
Generated 5/11/2026
Executive Summary
Mossman Associates is a Boston-based private biotechnology company founded in 2003, operating in the diagnostics and wellness technology sectors. The company's two primary product lines are the BioSound Therapy System, a non-invasive device for mental wellness and addiction support, and NicCheck I, an FDA-cleared, CLIA-waived urine test for semi-quantitative detection of nicotine and its metabolites. Mossman functions as a distributor and developer, providing solutions aimed at addiction management and mental wellness. Despite a long operating history, the company remains small and has not disclosed funding or valuation. Its niche positioning in addiction diagnostics and wellness may offer steady but limited growth potential, pending market adoption and regulatory developments.
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)